The HNSCC TCGA project also identified common mutations or deletions in the CYLD gene in HPV + HNSCC; as expected, mutations in CYLD result in enhanced NFκB signalling [84]. This evidence concerns the gene CYLD and head and neck squamous cell carcinoma.